期刊文献+

基于气相色谱法的帕瑞昔布钠中残留溶剂测定 被引量:5

Determination of Residual Solvents in PRXBN by GC
在线阅读 下载PDF
导出
摘要 采用顶空气相色谱法,建立帕瑞昔布钠中6种残留溶剂的测定方法.试样以N,N-二甲基甲酰胺(DMF)为溶剂,应用程序升温来测定.结果显示,乙醇、二氯甲烷、乙酸乙酯、正己烷、4-二甲氨基吡啶、三乙胺的定量限分别为5. 42μg、5. 62μg、5. 49μg、0. 3μg、3. 19 ng、0. 69μg;在0. 00965~6. 372 mg/m L范围内,各溶剂的峰面积与浓度呈良好的线性关系,平均回收率分别为100. 57%~104. 07%,RSD为0. 68%~2. 47%;方法完全适合用于本品的残留溶剂的测定. A method for determining the six residual organic solvents in parecoxib sodium is developed on headspace GC. Temperature programming is used for determination while N, N-Dimethylformamide(DMF) are taken as the solvent. The results show that the quantitative limits of ethyl alcohol, methylene dichloride, ethyl acetate, normal hexane, 4-dimethylaminopyridine, and triethylamine are 5.42 μg, 5.62μg, 5.49μg, 0.3 μg, 3.19 ng,0.69 μg respectively. The concentrations of the solvents are linear with the peak areas in the range of 0.00965 mg/mL- 6. 372 mg/mL. It is concluded that the average recovery rate is 100.57 % - 104.07 % (RSD: 0.68 % - 2.47 % ). The method is suitable for the determination of the residual solvent in parecoxib sodium.
作者 聂忠莉 毛玉萍 王晓玲 萧茂玲 张勇 黄金玉 郭瑞 NIE Zhongli;MAO Yuping;WANG Xiaoling;XIAO Maoling;ZHANG Yong;HUANG Jinyu;GUO Rui(School of Pharmacy and Bioengineering,Chengdu University,Chengdu 610106,China;Chengdu Climb Pharmaceutical Technology Co.,Ltd.,Chengdu 610041,China)
出处 《成都大学学报(自然科学版)》 2018年第3期260-263,共4页 Journal of Chengdu University(Natural Science Edition)
关键词 帕瑞昔布钠 残留溶剂 气相色谱法 方法学验证 parecoxib sodium residual solvent gas chromatography method validation
  • 相关文献

参考文献4

二级参考文献30

  • 1高枫,肖冰.帕瑞昔布对输尿管梗阻后肾功能的保护作用[J].陕西医学杂志,2008,37(11):1488-1489. 被引量:7
  • 2张祖列,闵苏.环氧化酶-2特异性抑制剂在心血管疾病中的应用及研究进展[J].重庆医学,2005,34(11):1742-1744. 被引量:6
  • 3Koboldt M, Talley JJ, Seibert K, et al. N- [ [ (5-Methyl-3- phenylisoxazol-4-yl) penyl] sulfonyl] propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration [J]. J Med Chem, 2000, 43 (5) : 775-777.
  • 4Letendre L J, Kunda SA, Gallagher DJ, et al. Method for preparing valdecoxib and related benzenesulfonyl compounds: WO, 2003029230 [P]. 2003-04-10. (CA 2003, 138: 304268).
  • 5Letendre L J, Snoddy CK, Klemm George H, et al. Method for the preparation of diarylisoxazole sulfonamide compounds and intermediates: WO, 2005123701 [P]. 2005-12-29. (CA 2005, 144: 88274).
  • 6Di NL, Vitale P, Scilimati A, et al. Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib:reversal cyclooxygenase-2selectivity by sulfonamide group removal [J]. J Med Chem, 2004, 47 (20) : 4881-4890.
  • 7Sundaram V, Bhimireddy A, Eswaraiah S, et al. A method for preparing 3,4-diphenylsubstituted isoxazole derivatives such as valdecoxib, parecoxib, and their intermediates: EP,1550658 [P].2005-07-06.
  • 8Thakashinamoorthy C, Jesudoss MG, Hariharasubramania M, et al. A novel process for preparing valdecoxib: WO, 2005085218 [P. 2005-09-15. (CA2005, 145: 124547).
  • 9乇凯,陈长谭,易安茂.一种制备帕瑞昔布的方法:中国,102329277[P].2012-01-25.
  • 10Reddy AR, Goverdhan G, Sampath A, et al. Application of [3+2]-cycloaddition in the synthesis of valdecoxib [J]. Synth Commun, 2012, 42 (5) : 639-649.

共引文献55

同被引文献23

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部